• MiR-3180, Lipid Metabolism, and HCC Progression

  2026-09-09

  Hong et al. identify miR-3180 as a regulator that restrains hepatocellular carcinoma by simultaneously limiting SCD1-associated fatty acid synthesis and CD36-mediated lipid uptake. The study combines patient-tissue analysis, molecular validation, cell-function assays, lipid measurements, and xenograft experiments to connect this regulatory axis with tumor growth, invasion, metastasis, and prognosis.

• Pregnenolone Carbonitrile: Assay Design Guide

  2026-09-09

  Pregnenolone Carbonitrile is more than a rodent PXR agonist: it can serve as a calibration probe for disease-state pharmacokinetics, CYP3A regulation, and liver fibrosis assays. This guide connects PCN mechanism with practical experimental decisions informed by a recent MASH pharmacokinetic study.

• SCH772984: An ERK1/2 Lens on Tumor Resistance

  2026-09-08

  SCH772984 is a selective ERK1/2 inhibitor that enables precise interrogation of MAPK signaling, tumor-cell fitness, and treatment resistance. This article connects its assay utility with the Ang II–HIF-1α–HILPDA findings in nasopharyngeal carcinoma while separating established evidence from testable hypotheses.

• TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury

  2026-09-07

  The reference study identifies TDRD9 as a suppressor of neutrophil cuproptosis and develops hyaluronic acid-coated peptide nanoparticles to deliver TDRD9 siRNA during Pseudomonas aeruginosa lung infection. Evidence from patient-derived neutrophils, mouse models, and human lung organoids links TDRD9 silencing to reduced neutrophil accumulation, bacterial burden, inflammation, and tissue injury through the PD-L1/CD80/p38 MAPK axis.

• NHS-Biotin Workflows for Protein Labeling

  2026-09-07

  NHS-Biotin provides a practical route to stable amine-directed labeling for antibody assays, intracellular studies, and streptavidin-based purification. Its short spacer and irreversible amide chemistry also make it useful for quality control around engineered nanobody assemblies, including the peptidisc-assisted systems described in recent research.

• SB203580 Workflow for p38 MAPK Inflammation Studies

  2026-09-05

  Build cleaner p38 MAPK experiments with SB203580, from soluble stock preparation to epithelial–neutrophil chemotaxis assays. The workflow connects pathway inhibition with inflammation, neuroprotection studies, and multidrug resistance reversal while highlighting concentration-dependent kinase selectivity and practical troubleshooting.

• Pam3CSK4: A Calibrated TLR1/2 Inflammation Probe

  2026-09-04

  Pam3CSK4 is a defined TLR1/2 agonist for dissecting immune activation, allergic inflammation, and neuroimmune regulation. This article presents a causal assay framework that separates direct innate immune signaling from TRPV1-driven systemic anti-inflammatory reflexes.

• Nerve-Driven HDAC1 Control in Axolotl Regeneration

  2026-09-04

  Wang and colleagues show that nerve-dependent HDAC1 expression is required for blastema formation and successful limb regeneration in axolotls. Their combination of pharmacological inhibition, denervation, and nerve-factor supplementation links neural signaling to epigenetic regulation at the wound epidermis, providing a mechanistic framework for studying regeneration.

• Vancomycin hydrochloride: Assay Reliability Guide

  2026-09-03

  This scenario-driven guide explains how Vancomycin hydrochloride, SKU B1223, can support Gram-positive bacteria inhibition, bacterial susceptibility testing, and antibiotic resistance assay design without being misapplied as a direct mammalian-cell viability reagent. It connects documented solubility, storage, and infection-model information with practical controls for reproducible laboratory workflows.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody for HMGB1

  2026-09-03

  Use this Cy3-labeled secondary antibody to convert mouse anti-HMGB1 binding into a sensitive, imageable signal across immunofluorescence, flow cytometry, and western blot workflows. The approach complements quantitative proteomics by adding spatial and cell-level validation for early diabetic nephropathy research.

• BIBR 1532: A Translational Playbook for Telomerase

  2026-09-02

  BIBR 1532 provides a mechanistically defined way to interrogate hTERT inhibition, telomere attrition, cancer cell proliferation inhibition, and apoptosis. This thought-leadership guide connects leukemia evidence with emerging telomere-focused combination biology while outlining a disciplined translational workflow.

• Moxifloxacin: Mechanism-to-Readout Assays

  2026-09-02

  Moxifloxacin is a fluoroquinolone antibiotic whose value extends beyond antibacterial screening. This guide presents a decision-based framework for connecting gyrase assays with retinal-cell, metabolic, and toxicity readouts while preserving mechanistic rigor.

• Exo1 for Golgi–ER Traffic and Exocytosis

  2026-09-01

  Exo1, or methyl 2-(4-fluorobenzamido)benzoate, provides an acute way to interrogate Golgi–ER membrane traffic and exocytic phenotypes. This article connects its ARF1-centered mechanism with tumor extracellular vesicle assays while clearly separating established evidence from hypothesis-generating applications.

• IR-820 for Near-Infrared Imaging Workflows

  2026-09-01

  IR-820 (New Indocyanine Green) supports practical vascular mapping, tumor visualization, and diseased tissue quantification with near-infrared fluorescence imaging. This guide translates its optical properties into a controlled workflow and shows how the reference study can inform, but not replace, direct validation of IR-820 in photothermal nanomedicine assays.

• ALT Cancer Cells and ATR Inhibition: No General Sensitivity

  2026-08-31

  Deeg and colleagues tested whether alternative lengthening of telomeres (ALT) creates a broadly exploitable vulnerability to the ATR inhibitor VE-821. Across multiple cell models and an isogenic ALT-suppression system, the study found no general ALT-associated hypersensitivity, emphasizing the importance of cell-line context and experimental controls.

8489 records 1/566 page Next 12345 下5页 Last page